Literature DB >> 2317941

Molecular size heterogeneity of immunoglobulins in health and disease.

P J Roberts-Thomson1, K Shepherd.   

Abstract

The molecular size of serum IgG, IgA and IgM in patients with a variety of monoclonal and polyclonal immune disorders has been determined by a sensitive immunoblotting technique. IgM, IgA and IgG3 paraproteins from patients with B cell lymphoproliferative disorders frequently polymerize with IgA paraproteins demonstrating two polymeric series, the basic unit of the more dominant series being monomeric IgA, and the second consists of a basic unit having a molecular mass of approximately 70 kD heavier than monomeric IgA. The molecular nature of this heavier IgA moiety was shown to be IgA covalently bound with a single molecule of serum albumin or alpha 1 antitrypsin and this moiety was also observed in small quantities in sera from healthy subjects. IgM paraproteins, particularly from patients with malignant lymphoproliferative disorders, consisted of varying proportions of decamers, pentamers and monomers together with other low molecular weight IgM oligomers. Paraproteins from patients with benign conditions showed less tendency to exist in multiple molecular weight forms. Serum immunoglobulins from patients with polyclonal immune disorder also showed molecular sized heterogeneity. Significantly increased levels of dimeric IgA were observed in patients with alcoholic cirrhosis and Felty's syndrome, while low molecular weight IgM was commonly seen in patients with autoimmune disorders. In these latter disorders monomeric IgM correlated significantly with the serum IgM level suggesting a disorder of assembly of the IgM subunits during an ongoing IgM immune response. We have demonstrated considerable molecular size heterogeneity of serum immunoglobulins both in health and disease and have indicated some possible clinical associations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317941      PMCID: PMC1534949          DOI: 10.1111/j.1365-2249.1990.tb08091.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Physicochemical and immunological studies of pathological serum macroglobulins.

Authors:  P RATCLIFF; J F SOOTHILL; D R STANWORTH
Journal:  Clin Chim Acta       Date:  1963-01       Impact factor: 3.786

2.  Relationship between paraprotein polymerization and clinical features in IgA myeloma.

Authors:  P J Roberts-Thomson; D Y Mason; I C MacLennan
Journal:  Br J Haematol       Date:  1976-05       Impact factor: 6.998

3.  IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis.

Authors:  A N Theofilopoulos; G Burtonboy; J J LoSpalluto; M Ziff
Journal:  Arthritis Rheum       Date:  1974 May-Jun

4.  A simple numerical method for the construction of isokinetic sucrose density gradients, and their application to the characterisation of immunoglobulin complexes.

Authors:  P Johns; D R Stanworth
Journal:  J Immunol Methods       Date:  1976-03       Impact factor: 2.303

5.  Identification of a lymphocyte enzyme that catalyzes pentamer immunoglobulin M assembly.

Authors:  R A Roth; M E Koshland
Journal:  J Biol Chem       Date:  1981-05-10       Impact factor: 5.157

6.  Immunochemical studies in four cases of alpha chain disease.

Authors:  M Seligmann; E Mihaesco; D Hurez; C Mihaesco; J L Preud'homme; J C Rambaud
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

7.  Low molecular weight IgM in rheumatoid arthritis and other rheumatic diseases.

Authors:  P J Roberts-Thomson; R M Wernick; M Ziff
Journal:  Arthritis Rheum       Date:  1981-06

8.  Human myeloma IgA half-molecules.

Authors:  H L Spiegelberg; B G Fishkin
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

9.  IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA.

Authors:  M L Trascasa; J Egido; J Sancho; L Hernando
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

10.  Presence of J chain in human lymphoid cells.

Authors:  J Mestecky; J L Preud'homme; S S Crago; E Mihaesco; J T Prchal; A J Okos
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

View more
  4 in total

1.  Comparative Structural Study of Terminal Ends of Lipoarabinomannan from Mice Infected Lung Tissues and Urine of a Tuberculosis Positive Patient.

Authors:  Prithwiraj De; Libin Shi; Claudia Boot; Diane Ordway; Michael McNeil; Delphi Chatterjee
Journal:  ACS Infect Dis       Date:  2019-12-12       Impact factor: 5.084

2.  Challenges facing lipoarabinomannan urine antigen tests for diagnosing HIV-associated tuberculosis.

Authors:  Robin Wood; Stephen D Lawn
Journal:  Expert Rev Mol Diagn       Date:  2012-07       Impact factor: 5.225

3.  Structural and functional consequences of cleavage of human secretory and human serum immunoglobulin A1 by proteinases from Proteus mirabilis and Neisseria meningitidis.

Authors:  Adel Almogren; Bernard W Senior; Lesley M Loomes; Michael A Kerr
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

4.  Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria.

Authors:  Robin Wood; Kimberly Racow; Linda-Gail Bekker; Keren Middelkoop; Monica Vogt; Barry N Kreiswirth; Stephen D Lawn
Journal:  BMC Infect Dis       Date:  2012-02-27       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.